Rapilysin Eiropas Savienība - maltiešu - EMA (European Medicines Agency)

rapilysin

actavis group ptc ehf - reteplase - infart mijokardijaku - aġenti antitrombotiċi - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.

Insulin aspart Sanofi Eiropas Savienība - maltiešu - EMA (European Medicines Agency)

insulin aspart sanofi

sanofi winthrop industrie - insulin aspart - diabetes mellitus - drogi użati fid-dijabete - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.